Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19
Condition(s):Severe Acute Respiratory SyndromeLast Updated:January 11, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Severe Acute Respiratory SyndromeLast Updated:January 11, 2021Unknown status
Condition(s):Coronavirus Disease 2019Last Updated:August 25, 2021Completed
Condition(s):Severe Acute Respiratory SyndromeLast Updated:November 29, 2023Completed
Condition(s):HealthyLast Updated:July 2, 2017Completed
Condition(s):COVID-19; SARS-CoV 2; Corona Virus Infection; Sedentary BehaviorLast Updated:October 22, 2020Completed
Condition(s):Covid19; SARS-CoV Infection; Pulmonary Function; Pneumonia, ViralLast Updated:February 23, 2023Active, not recruiting
Condition(s):COVID-19; Pneumonia; Acute Respiratory Distress SyndromeLast Updated:December 29, 2020Completed
Condition(s):Covid19; COVID-19 Pneumonia; SARS-CoV-2 InfectionLast Updated:July 20, 2021Completed
Condition(s):Covid19Last Updated:March 30, 2021Unknown status
Condition(s):History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 InfectionLast Updated:April 9, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.